Skip to main content
CLNN
NASDAQ Life Sciences

10% Owner Sells $251K in Clene Inc. Shares Amid Going Concern Doubts

Analysis by Wiseek.ai
Sentiment info
Negative
Importance info
7
Price
$6.31
Mkt Cap
$74.321M
52W Low
$2.28
52W High
$13.5
Market data snapshot near publication time

summarizeSummary

A 10% owner of Clene Inc. sold over $251,000 worth of shares, continuing a pattern of insider distribution while the company faces going concern uncertainties.


check_boxKey Events

  • 10% Owner Sells Shares

    Ugwumba Chidozie, a 10% owner, disposed of 39,162 shares of Clene Inc. common stock through open market sales.

  • Significant Transaction Value

    The sales totaled approximately $251,898, occurring across three transactions between April 15 and April 17, 2026.

  • Context of Financial Uncertainty

    These sales occur after the company's recent 10-K filing disclosed substantial doubt about its ability to continue as a going concern, adding to negative sentiment.

  • Reinforces Insider Distribution Trend

    This transaction contributes to a broader pattern of insider distribution, with over $1 million in net insider sales reported in the last 90 days.


auto_awesomeAnalysis

This Form 4 reports open market sales by Ugwumba Chidozie, a 10% owner, totaling approximately $251,898. This transaction represents a notable disposition of shares, especially in the context of Clene Inc.'s recent 10-K filing which expressed substantial doubt about its ability to continue as a going concern. While 10% owners are often financial investors whose sales may be for portfolio rebalancing, the timing of this sale, coupled with a broader pattern of insider distribution and the company's financial challenges, could be perceived negatively by the market. Investors should monitor further insider activity and the company's progress on its clinical programs and financial stability.

At the time of this filing, CLNN was trading at $6.31 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $74.3M. The 52-week trading range was $2.28 to $13.50. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed CLNN - Latest Insights

CLNN
Apr 28, 2026, 4:10 PM EDT
Filing Type: 144
Importance Score:
7
CLNN
Apr 22, 2026, 5:55 PM EDT
Filing Type: 4
Importance Score:
7
CLNN
Apr 17, 2026, 8:17 PM EDT
Filing Type: 4
Importance Score:
7
CLNN
Apr 15, 2026, 4:05 PM EDT
Filing Type: 144
Importance Score:
8
CLNN
Apr 10, 2026, 4:06 PM EDT
Filing Type: DEFA14A
Importance Score:
8
CLNN
Apr 10, 2026, 4:05 PM EDT
Filing Type: DEF 14A
Importance Score:
8
CLNN
Mar 31, 2026, 5:05 PM EDT
Filing Type: 144
Importance Score:
7
CLNN
Mar 31, 2026, 4:35 PM EDT
Filing Type: 4
Importance Score:
7
CLNN
Mar 24, 2026, 4:36 PM EDT
Filing Type: 144
Importance Score:
8
CLNN
Mar 17, 2026, 7:00 AM EDT
Filing Type: 10-K
Importance Score:
9